ENTITY
Glenmark Pharmaceuticals

Glenmark Pharmaceuticals (GNP IN)

167
Analysis
Health Care • India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
bearish•Pvr Inox
•08 Aug 2020 22:43

Forensic Accounting | High Risk Companies in India

As promised at Smartkarma Webinar | Accounting and Insider Diagnostics, we have extended our forensic analysis model to India. To learn more about...

Logo
595 Views
Share
•05 Aug 2020 15:54

Asia HY Monthly - LARA And Credit Bias Study (2020 Update) - Lucror Analytics

In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments for companies under our coverage over the past few years,...

Logo
478 Views
Share
bullish•Parkway Pantai Ltd
•03 Aug 2020 00:19

Parkway Pantai: Good Brand with Limited Upside

We initiate our coverage of Parkway Pantai Ltd (0794727D SP) (Parkway Pantai), a wholly-owned subsidiary of IHH Healthcare (IHH MK) of which major...

Logo
528 Views
Share
•30 Jul 2020 08:54

Morning Views Asia: Glenmark Pharmaceuticals, Redco Properties

Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...

Logo
337 Views
Share
•28 Jul 2020 17:09

Asia HY Trade Recommendations - July 2020 - Lucror Analytics

The Asia HY Trade Recommendations report for the month of July includes a summary of our recommendations, as well as our high-conviction ideas....

Logo
360 Views
Share
x